Európai Unió - szlovén - EMA (European Medicines Agency)

passauer pharma gmbh - mofetilmikofenolat - zavrnitev presadka - imunosupresivi - myclausen je indiciran v kombinaciji s ciklosporinom in kortikosteroidi za profilakso akutne zavrnitve presadka pri bolnikih, ki so prejemali alogenske ledvične, srčne ali jetrne presaditve.

Európai Unió - szlovén - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinalni stromalni tumorji - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Európai Unió - szlovén - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - limfom, mantle cell - proteinska kinaza inhibitorji - treatment of mantle cell lymphoma (mcl).

Európai Unió - szlovén - EMA (European Medicines Agency)

hra pharma rare diseases - ketokonazol - cushingov sindrom - antimikotiki za sistemsko uporabo - ketokonazol hra je indiciran za zdravljenje endogenega cushingovega sindroma pri odraslih in mladostnikih, starejših od 12 let.

Európai Unió - szlovén - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastična sredstva - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Európai Unió - szlovén - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - dermatitis, atopic - drugi dermatološki preparati - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

Európai Unió - szlovén - EMA (European Medicines Agency)

roche registration gmbh - sakvinavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - zdravilo invirase je indicirano za zdravljenje odraslih bolnikov s hiv-1. zdravilo invirase se lahko daje le v kombinaciji z ritonavirjem in drugimi protiretrovirusnimi zdravili.

Európai Unió - szlovén - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Európai Unió - szlovén - EMA (European Medicines Agency)

laboratoires delbert - histamin dihydrochloride - leukemija, myeloid, akutna - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). učinkovitost zdravila ceplene ni bila v celoti dokazana pri bolnikih, starejših od 60 let.

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ipsen pharma - heksaminolevulinat - prašek in vehikel za intravezikalno raztopino - heksaminolevulinat 85 mg / 1 viala - heksaminolevulinat